Phio Pharmaceuticals Corp (PHIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 7,387 | 10,824 | 11,462 | 13,511 | 8,793 |
| Operating Income | -7,387 | -10,824 | -11,462 | -13,511 | -8,793 |
| Other Income | 237 | -2 | -18 | 224 | -1 |
| Pre-tax Income | -7,150 | -10,826 | -11,480 | -13,287 | -8,794 |
| Net Income Continuous | -7,150 | -10,826 | -11,480 | -13,287 | -8,794 |
| Net Income | $-7,150 | $-10,826 | $-11,480 | $-13,287 | $-8,794 |
| EPS Basic Total Ops | -9.08 | -46.76 | -90.91 | -111.88 | -207.46 |
| EPS Basic Continuous Ops | -9.09 | -46.66 | -90.88 | -111.88 | -207.16 |
| EPS Diluted Total Ops | -9.08 | -46.76 | -90.91 | -111.88 | -207.46 |
| EPS Diluted Continuous Ops | -9.09 | -46.66 | -90.88 | -111.88 | -207.16 |
| EPS Diluted Before Non-Recurring Items | -9.08 | -46.81 | -90.91 | -112.38 | -207.46 |
| EBITDA(a) | $-7,385 | $-10,768 | $-11,391 | $-13,436 | $-8,721 |